Accessibility Menu
Phibro Animal Health logo

Phibro Animal Health(NASDAQ) PAHC

Market Cap$1.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+169%
5 Year+76%
1 Year+14%
1 Month-0%
Premium Feature
Moneyball Superscore
67/100
$36.45
+1.00%
+0.36Today
After hours$36.29-$0.16 (-0.44%)
Phibro Animal Health last closing stock price
MetricPriceDate
Last closeUSD 36.352026-08-27
Phibro Animal Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.33%USD 35.182026-08-20
1 month-0.05%USD 36.372026-07-28
3 month+18.56%USD 30.662026-05-29
Year to date-2.07%USD 37.122025-12-31
1 year+14.31%USD 31.802025-08-27
3 year+160.09%USD 13.982023-08-28
5 year+75.99%USD 20.652021-08-27
Since inception+168.68%USD 13.432014-04-11

Phibro Animal Health Financials at a Glance

Market Cap

$1.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.52B

Net Income (TTM)

$99.72M

EPS (TTM)

$2.43

P/E Ratio

14.93

Dividend

$0.48

Beta (Volatility)

0.91 (Low)

Price

$36.45

Volume

432,907

Open

$39.39

Previous Close

$36.35

Daily Range

$35.01 - $39.39

52-Week Range

$28.25 - $60.08

Estimated Earnings Date

Nov 4, 2026

PAHC News

PiggyBank-BuyAlert-Purple.png

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

Cory RenauerJun 13, 2026
SellAlert-Green.png

Phibro's CEO transition puts this insider sale in context

Seena HassounaMay 23, 2026
SellAlert-Green.png

Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million

Cory RenauerApr 28, 2026
SellAlert-Green.png

Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell?

Robert IzquierdoFeb 27, 2026
SellAlert-Blue.png

Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance

Adé HennisFeb 22, 2026
Foolcom-Featured.png

Phibro Animal Health Q4 Revenue Up 39%

Motley Fool Markets TeamAug 27, 2025
woman riding horse outside nature animal

Why Shares of Phibro Animal Health Are Dropping This Week

James HalleySep 7, 2023
puppyandkitten

3 Pet Med Stocks That Offer Growth and a Nice Dividend

James HalleyJun 2, 2020
Page 1

PAHC: Motley Fool Moneyball Superscore

67

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Phibro Animal Health

Phibro Animal Health Corporation helps farmers keep livestock healthy. It makes medicines and vaccines for animals like cows and chickens. These products help provide safe and affordable food for people.

Helping Animals Stay Healthy

  • Animal Health: Medicated feed additives, vaccines, and nutritional specialties for livestock and companion animals; accounts for 77% of net sales in fiscal year 2026.
  • Mineral Nutrition: Trace mineral formulations used to balance animal diets and maintain health; represents 19% of net sales in fiscal year 2026.
  • Performance Products: Specialty ingredients for personal care, industrial chemicals, and chemical catalysts; makes up 5% of net sales in fiscal year 2026.

Strategic Moves and New Sites

  • Completed a $297.5 million purchase of a medicated feed additive portfolio from Zoetis in October 2024.
  • Launched the Restoris canine dental device in October 2025 to expand its companion animal offerings.
  • Expanded production capacity in Omaha, Nebraska, and Guarulhos, Brazil, during fiscal years 2024 and 2023.
  • Decided to close the Chicago Heights manufacturing facility in August 2026 to consolidate operations.

Global Reach and Resources

Phibro reaches customers in approximately 90 countries through a dedicated technical and sales network. The company operates manufacturing sites in the United States, Israel, Brazil, Italy, and China to ensure product supply.

Performance by the Numbers

  • Net sales reached $1.5 billion in fiscal year 2026, up 17% year over year.
  • Gross profit was $512.5 million in fiscal year 2026, up 28% year over year.
  • Operating income was $194.4 million in fiscal year 2026, up 76% year over year.
  • Net income reached $99.7 million in fiscal year 2026.

Evolution of the Business

Phibro has shifted from a chemical business to a major global provider of animal health and nutrition solutions. Recent acquisitions and manufacturing expansions support its focus on large-scale livestock production.

AI Generated • Aug 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,605

CEO

Jack C. Bendheim

Website

www.pahc.com

Headquarters

Teaneck, NJ 07666-6712, US

PAHC Financials

Key Financial Metrics (TTM)

Gross Margin

33.71%

Operating Margin

13.07%

Net Income Margin

6.57%

Return on Equity

28.67%

Return on Capital

20.31%

Return on Assets

6.64%

Earnings Yield

6.70%

Dividend Yield

1.32%

Payout Ratio

19.52%

Stock Overview

Market Cap

$1.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

40.56M

Volume

432.91K

Avg. Volume

268.17K

Financials (TTM)

Gross Profit

$511.71M

Operating Income

$198.44M

EBITDA

$236.46M

Operating Cash Flow

$68.95M

Capital Expenditure

-$59.09M

Free Cash Flow

$9.87M

Cash & ST Invst.

$81.99M

Total Debt

$591.77M

Phibro Animal Health Performance Analysis

Phibro Animal Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30USD 977,889,0003.8%
20242024-06-30USD 1,017,679,0004.1%
20252025-06-30USD 1,296,215,00027.4%
20262026-06-30USD 1,518,093,00017.1%
Phibro Animal Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30-3.9%
Q22025-12-312.8%
Q32026-03-312.6%
Q42026-06-303.4%
Phibro Animal Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30USD 0.81-33.7%
20242024-06-30USD 0.06-92.6%
20252025-06-30USD 1.191890.8%
20262026-06-30USD 2.43105.2%
Phibro Animal Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-3054.8%
Q22025-12-313.1%
Q32026-03-31-11.9%
Q42026-06-30-10.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$396.75M

+4.8%

Gross Profit

$134.40M

+22.2%

Gross Margin

33.88%

N/A

Market Cap

$1.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$595.77K

N/A

Employees

2,475

N/A

Net Income

$21.71M

+26.0%

EBITDA

$55.87M

+24.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$81.99M

+6.4%

Total Debt

$591.77M

-22.3%

Accounts Receivable

$238.79M

+4.7%

Inventory

$534.88M

+20.4%

Long Term Debt

$591.77M

-19.6%

Short Term Debt

$35.60M

+40.3%

Return on Assets

6.64%

N/A

Return on Invested Capital

16.75%

N/A

Free Cash Flow

$5.23M

-35.7%

Operating Cash Flow

$24.09M

+13.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALVOAlvotech
$4.88-0.61%
MNKDMannKind Corporation
$4.06-0.73%
ANIPANI Pharmaceuticals, Inc.
$73.51-1.41%
AUPHAurinia Pharmaceuticals Inc.
$16.48-0.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$227.98+0.09%
INTCIntel
$92.09+0.04%
BITOProShares Trust - ProShares Bitcoin ETF
$10.78+0.02%
ONDSOndas
$8.75+0.06%

Questions About PAHC

What is the current price of Phibro Animal Health?

Phibro Animal Health is trading at $36.35 per share.

What is the 52-week range for Phibro Animal Health?

Over the past 52 weeks, Phibro Animal Health has traded between $28.25 and $60.08.

How much debt does Phibro Animal Health have?

As of the most recent reporting period, Phibro Animal Health reported total debt of $788.77M.

How much cash does Phibro Animal Health have on hand?

Phibro Animal Health reported $61.42M in cash and cash equivalents in its most recent financial results.

What is Phibro Animal Health’s dividend yield?

Phibro Animal Health currently has a dividend yield of 1.32%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services